# Surgical Idiopathic Intracranial Hypertension Treatment Trial

> **NCT03501966** · PHASE3 · TERMINATED · sponsor: **Jaeb Center for Health Research** · enrollment: 7 (actual)

## Conditions studied

- Idiopathic Intracranial Hypertension

## Interventions

- **DRUG:** Acetazolamide
- **PROCEDURE:** Optic Nerve Sheath Fenestration
- **PROCEDURE:** Ventriculoperitoneal CSF Shunting

## Key facts

- **NCT ID:** NCT03501966
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-06
- **Primary completion:** 2019-08-28
- **Final completion:** 2019-08-28
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2022-06-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501966, "Surgical Idiopathic Intracranial Hypertension Treatment Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03501966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*